Severe nitrofurantoin lung disease resolving without the use of steroids

Journal of Postgraduate Medicine

Volumn 53, Issue 2, 2007, Pages 111-113

  Bhullar, S ^a   Lele, S ^a   Kraman, S ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Abnormalities; Drug hypersensitivity; Drug induced; Interstitial; Lung diseases

Indexed keywords

ACETYLSALICYLIC ACID; NITROFURANTOIN; OMEPRAZOLE; STEROID;

AGED; ARTICLE; BRONCHOSCOPY; CASE REPORT; CHRONIC LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DELAYED DIAGNOSIS; DISEASE ASSOCIATION; DRUG WITHDRAWAL; DYSPNEA; FEMALE; HUMAN; LONG TERM CARE; LUNG BIOPSY; OUTCOME ASSESSMENT; SELF CARE; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT RESPONSE; URINARY TRACT INFECTION;

EID: 34249327732     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: 10.4103/0022-3859.32211     Document Type: Article

References (18)

1. Bidad K, Harries-Jones R. Nitrofurantoin lung injury. Age Ageing 2004;33:414-5.
2. Jick SS, Jick H, Walker AM, Hunter JR. Hospitalizations for pulmonary reactions following nitrofurantoin use. Chest 1989;96:512-5.
3. Magee F, Wright JL, Chan N, Currie W, Karr G, Hogg J, et al. Two unusual pathological reactions to nitrofurantoin: Case reports. Histopathology 1986;10:701-6.
4. Witten CM. Pulmonary toxicity of nitrofurantoin. Arch Phys Med Rehabil 1989;70:55-7.
5. Yalcin S, Sahin A, Yalcin B, Altinok G. Nitrofurantoin toxicity to both liver and lungs. Liver 1997;17:166-7.
6. Hallas J, Gram LF, Grodum E, Damsbo N, Brosen K, Haghfelt T, et al. Drug related admissions to medical wards: A population based survey. Br J Clin Pharmacol 1992;33:61-8.
7. Holmberg L, Boman G. Pulmonary reactions to nitrofurantoin. 447 cases reported to the Swedish Adverse Drug Reaction Committee 1966-1976. Eur J Respir Dis 1981;62:180-9.
8. Holmberg L, Boman G, Bottiger LE, Eriksson B, Spross R, Wessling A. Adverse reactions to nitrofurantoin. Analysis of 921 reports. Am J Med 1980;69:733-8.
9. Perez Herms S, Castellanos Acosta R, Guzman Fernandez A, Cortadellas Angel R, Ballesteros Sampol JJ. Pulmonary fibrosis secondary to nitrofurantoin. Arch Esp Urol 1992;45:577-8.
10. Qureshi MM. Interstitial lung disease caused by chronic nitrofurantoin reaction; case report. Wis Med J 1984;83:20-2.
11. Robinson GM, Bai TR, Steele RH. Nitrofurantoin induced chronic pulmonary reaction: Case report. N Z Med J 1980;91:50-2.
12. Ruikka I, Vaissalo T, Saarimaa H. Progressive pulmonary fibrosis during nitrofurantoin therapy. A case history with autopsy report. Scand J Respir Dis 1971;52:162-6.
13. Cameron RJ, Kolbe J, Wilsher ML, Lambie N. Bronchiolitis obliterans organising pneumonia associated with the use of nitrofurantoin. Thorax 2000;55:249-51.
14. Fawcett IW, Ibrahim NB. BOOP associated with nitrofurantoin. Thorax 2001;56:161.
15. Mendez JL, Nadrous HF, Hartman TE, Ryu JH. Chronic nitrofurantoin-induced lung disease. Mayo Clin Proc 2005;80:1298-302.
16. rd, DeRemee RA, Dines DE. Chronic nitrofurantoin pulmonary reaction. Report of 5 cases. N Engl J Med 1968;279:1258-62.
17. Sheehan RE, Wells AU, Milne DG, Hansell DM. Nitrofurantoin-induced lung disease: two cases demonstrating resolution of apparently irreversible CT abnormalities. J Comput Assist Tomogr 2000;24:259-61.
18. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.